ScholarWorks@Korea University College of Medicine: Eo, Jae Seon

Detailed Information

Eo, Jae Seon(어재선)

구로병원 (Department of Nuclear Medicine, Guro Hospital)

Research Area: Nuclear Medicine, Molecular Imaging, Theranosis

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

CT:7||PET:6||s disease:4||Metabolic tumor volume:3||prognosis:3||Prognosis:3||Liver malignancy:2||F18FDG:2||Multicenter trial:2||survival:2||F18FDG PET:2||Hepatocellular carcinoma:2||Standardized uptake value:2||18FFDG PET/CT:2||Positron emission tomography:2||Alzheimer&apos:2||18FFDGPET/CT:2||hepatocellular carcinoma:2||Total lesion glycolysis:2||FDGPET:2||Amyloid:2||Coronavirus:1||Deep learning:1||Depression:1||Diagnostic value:1||Effective dose:1||Ezetimibe:1||F18FDG PET/CT:1||FDG PET:1||FDG PET/CT:1||FDGPET/CT:1||Ga68:1||Guidelines:1||Haematopoietic activity:1||Hypometabolism:1||Inguinal hernia:1||International prognostic index:1||Ki67:1||Latelife depression:1||Liver metastasis:1||Lung cancer:1||Mammographic density:1||Maximal standardized uptake value:1||Mediastinal lymph node:1||Mediastinal lymph node dissection:1||Memory:1||Metastasectomy:1||Metastatic mucinous adenocarcinoma:1||Microsphere:1||Microvascular invasion:1||Mild cognitive impairment:1||Myocardial infarction:1||Neoadjuvant chemotherapy:1||Nonsmallcell lung cancer:1||Nonsmallcell lung carcinoma:1||Nuclear imaging:1||Nuclear medicine:1||Ovarian cancer:1||PEM (positron emission mammography):1||PET computed tomographic:1||PET/CT:1||PETscan:1||Parkinson&apos:1||Peripheral Tcell lymphoma:1||Plaque inflammation:1||Pooled cohort risk scores:1||Positron emission mammography:1||Positron emission tomographycomputed tomography:1||Practice guideline:1||Prediction:1||Prevention and control:1||RGD peptide:1||Radioembolization:1||SUV:1||Segmentation:1||Sensitivity:1||Singlephoton emission computerized tomography:1||Smallcell lung carcinoma:1||Statin:1||Statistical probabilistic anatomical mapping:1||Tc99mMAA:1||Textural features:1||Theragnosis:1||Transplantation:1||Treatment:1||Vascular inflammation:1||Visual assessment:1||Wilson&apos:1||Y90:1||advanced gastric cancer:1||amyloid:1||atherosclerosis:1||breast cancer:1||bronchial mucous gland adenoma:1||cervical cancer:1||concurrent chemoradiotherapy:1||depression:1||fluoropyrimidine:1||hypometabolism:1||inflammation:1||interim 18FFDG PET:1||lung cancer:1||mannose receptor:1||mild cognitive impairment:1||myocardial infarction:1||positron emission tomography:1||recurrence:1||response:1||therapeutic angiogenesis:1||total lesion glycolysis:1||transarterial chemoembolization:1||tumor:1||123IbetaCIT:1||volumetric parameter:1||18FFDGPET/CT:1||Alzheimer disease:1||Amygdalar activity:1||Angiogenesis:1||Arterial inflammation:1||Automated analysis:1||Background F18FDG uptake:1||Background parenchymal enhancement (BPE):1||Breast MRI:1||Breast cancer:1||COVID19:1||CT perfusion:1||Cancers metastatic to the lung:1||Cellfree nucleic acids quantification:1||Cervical cancer:1||Chemoradiotherapy:1||Cognitive dysfunction:1||Colon cancer:1||Colorectal cancer:1||Coronary artery calcification:1||

STATISTICS: Total View :7,654,741; Today View :8,501

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841) 82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE